Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

TEPADINA 400 MG

THIOTEPA : 400 MG · DIN 02523906 · ADIENNE SA

Health Canada status: DORMANT

What is TEPADINA?

TEPADINA 400 MG contains THIOTEPA : 400 MG. It is listed in the Health Canada Drug Product Database under DIN 02523906, held by ADIENNE SA, supplied as POWDER FOR SOLUTION for INTRAVENOUS administration. Health Canada currently lists it as dormant, status dated 31-Jul-2026. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

What is TEPADINA used for?

TEPADINA, in combination with other chemotherapeutic products as part of a high-dose chemotherapy (HDCT) consolidation regimen followed by autologous stem cell transplantation (ASCT) for adult patients with central nervous system (CNS) lymphoma, has been issued marketing authorization with conditions, pending the results of trials to verify its clinical benefit. Patients should be advised of the nature of the authorization.

Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.

Product details and regulatory record

DIN02523906
Brand nameTEPADINA
Generic / active ingredientTHIOTEPA : 400 MG
ManufacturerADIENNE SA
Strength400 MG
Dosage formPOWDER FOR SOLUTION
Route of administrationINTRAVENOUS
SchedulePrescription
ATC codeL01AC01 THIOTEPA
AHFS class10:00.00
BiosimilarNo
Health Canada statusDORMANT
Status date31-Jul-2026
Original market date2025-06-25 00:00:00

How is it stored and handled?

null

How is it supplied?

1 vial; 1 bag

What can be used instead?

Other Canadian products sharing ATC code L01AC01 THIOTEPA. 6 of 9 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
TEPADINA100 MGPOWDER FOR SOLUTIONADIENNE SAMARKETEDDIN 02462702
TEPADINA15 MGPOWDER FOR SOLUTIONADIENNE SAMARKETEDDIN 02462680
THIOTEPA FOR INJECTION USP100 MGPOWDER FOR SOLUTIONSTERIMAX INCMARKETEDDIN 02526425
THIOTEPA FOR INJECTION USP15 MGPOWDER FOR SOLUTIONSTERIMAX INCMARKETEDDIN 02526417
THIOTEPA FOR INJECTION, BP100 MGPOWDER FOR SOLUTIONHIKMA CANADA LIMITEDMARKETEDDIN 02536870
THIOTEPA FOR INJECTION, BP15 MGPOWDER FOR SOLUTIONHIKMA CANADA LIMITEDMARKETEDDIN 02536862
THIO TEPA INJ 15MG/VIAL15 MGPOWDER FOR SOLUTIONLEDERLE CYANAMID CANADA INC.CANCELLED POST MARKETDIN 00237035
THIOTEPA - (PWS 15 MG/VIAL)15 MGPOWDER FOR SOLUTIONWYETH CANADACANCELLED POST MARKETDIN 02174391

Who else supplies THIOTEPA worldwide?

Nexara tracks national medicine registries and published price lists across multiple markets. THIOTEPA appears in 31 registered pack listings across 6 markets, published on 5 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.

Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for TEPADINA

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Request a quote for TEPADINA

Health Canada Drug Product Database (DPD), DIN 02523906. Last reviewed 2026-09-08. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.